AR suppression rewires a SOX4 regulatory program to promote enzalutamide resistance in prostate cancer
Sini Hakkola, Anni Perämäki, Antti Kiviaho…·Mikael Marttinen
The paper identifies a SOX4-driven regulatory program that promotes enzalutamide resistance in prostate cancer by rewiring gene regulation following AR suppression.